CORC

浏览/检索结果: 共2145条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载:9/0  |  提交时间:2023/11/10
Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Peng, Chanjuan;  Yi, Dan;  Zhou, Ying;  Yao, Jincao;  Chen, Bo
收藏  |  浏览/下载:11/0  |  提交时间:2022/12/23
Deep learning radiomics of dual-modality ultrasound images for hierarchical diagnosis of unexplained cervical lymphadenopathy 期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:  Zhu,Yangyang;  Meng,Zheling;  Fan,Xiao;  Duan,Yin;  Jia,Yingying
收藏  |  浏览/下载:40/0  |  提交时间:2022/09/19
Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry 期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 卷号: 15
作者:  Liu, Long;  Yu, Xingxing;  Li, Zhifeng;  He, Xiaohua;  Zha, Jie
收藏  |  浏览/下载:116/0  |  提交时间:2022/12/23
The Prognostic Utility of F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients 期刊论文
FRONTIERS IN ONCOLOGY, 2022, 卷号: 12
作者:  Li, Cong;  Yu, Haifeng;  Chen, Xi;  Han, Shuiyun;  Peng, Shuailing
收藏  |  浏览/下载:12/0  |  提交时间:2022/12/23
Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: a case report 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 卷号: 11
作者:  Gu, Xiaodong;  Wang, Wenxian;  Wu, Wei;  Zhang, Yiping;  Shao, Lan
收藏  |  浏览/下载:10/0  |  提交时间:2022/12/22
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
收藏  |  浏览/下载:13/0  |  提交时间:2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载:27/0  |  提交时间:2022/05/05
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2 期刊论文
LEUKEMIA, 2022
作者:  Yang, Jing;  Weisberg, Ellen L.;  Qi, Shuang;  Ni, Wei;  Mei, Husheng
收藏  |  浏览/下载:73/0  |  提交时间:2022/02/14
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
作者:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao
收藏  |  浏览/下载:40/0  |  提交时间:2022/02/14


©版权所有 ©2017 CSpace - Powered by CSpace